Monte Rosa Therapeutics shares owned by Aisling Capital Management
Quarter-by-quarter ownership of Monte Rosa Therapeutics (GLUE) shares owned by Aisling Capital Management
from 13F filings
Historical chart of Aisling Capital Management investment in Monte Rosa Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Monte Rosa Therapeutics held by Aisling Capital Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Monte Rosa Therapeutics by Aisling Capital Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-06-30 | $5.5M | 1.5M | 3.74 |
| 2024-03-31 | $10M | 1.5M | 7.05 |
| 2023-12-31 | $8.3M | 1.5M | 5.65 |
| 2023-09-30 | $7.1M | 1.5M | 4.79 |
| 2023-06-30 | $10M | 1.5M | 6.85 |
| 2023-03-31 | $12M | 1.5M | 7.79 |
| 2022-12-31 | $11M | 1.5M | 7.61 |
| 2022-09-30 | $12M | 1.5M | 8.17 |
| 2022-06-30 | $14M | 1.5M | 9.67 |
| 2022-03-31 | $21M | 1.5M | 14.02 |
| 2021-12-31 | $30M | 1.5M | 20.42 |
| 2021-09-30 | $33M | 1.5M | 22.28 |
| 2021-06-30 | $33M | 1.5M | 22.70 |
More positions owned by Aisling Capital Management
View all positions for Aisling Capital Management